Clinical Trial Update: Study of the Efficacy, Safety, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of BCD-261 in Subjects With Moderate to Severe Active Ulcerative Colitis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial investigating the efficacy, safety, pharmacokinetics, pharmacodynamics, and immunogenicity of BCD-261 in adults with moderate to severe a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• BCD-261

Snippet

Sponsor: Biocad | Conditions: Ulcerative Colitis (UC) | Phase 2 | Status: RECRUITING